Omeros OMER
NASDAQ OMER
$18.95 -0.16 (-0.84%)
At close: Sep 4, 2026 · 4:00 PM EDT

Omeros (OMER) Cash from Investing Activities (2010 - 2026)

Omeros (OMER) posted Cash from Investing Activities of $28.7 million for Q1 2026, down 74.24% sequentially from $111.5 million in Q4 2025, and down 25.45% YoY from $38.5 million in Q1 2025.

Analysis

Omeros (OMER) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Omeros has reported Cash from Investing Activities for 17 years, with the latest figure at $28.7 million in Q1 2026.

  • Quarterly Cash from Investing Activities fell 25.45% year-over-year to $28.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $154.7 million (down 15.31% YoY) and the FY2025 annual result came in at $164.5 million, up 100.11% from the prior year.
  • Cash from Investing Activities slipped to $28.7 million in Q1 2026 per OMER's latest filing, from $111.5 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $116.2 million in Q4 2023 and troughed at -$181.3 million in Q1 2023.
  • A 5-year average of $10.3 million and a median of $33.0 million in 2022 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities sank 332.87% in 2022, then jumped 219.12% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$108.5 million in 2022, then surged by 207.15% to $116.2 million in 2023, then plunged by 69.93% to $35.0 million in 2024, then surged by 219.12% to $111.5 million in 2025, then sank by 74.24% to $28.7 million in 2026.
  • According to Business Quant data, Cash from Investing Activities over the past three periods registered $28.7 million, $111.5 million, and -$6.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -45.80 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -92.70 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 329.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -1.66 Bn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -49.35 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -363.46 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - -229.72 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 24.51 Mn
10 Omeros 1.38 Bn 1.38 Bn 27.73 Mn 3.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.40 Mn
Mar 31, 2026 28.73 Mn
Dec 31, 2025 111.55 Mn
Sep 30, 2025 -6.86 Mn
Jun 30, 2025 21.30 Mn
Mar 31, 2025 38.54 Mn
Dec 31, 2024 34.95 Mn
Sep 30, 2024 36.04 Mn
Jun 30, 2024 73.15 Mn
Mar 31, 2024 -61.93 Mn
Dec 31, 2023 116.24 Mn
Sep 30, 2023 57.17 Mn
Jun 30, 2023 35.38 Mn
Mar 31, 2023 -181.33 Mn
Dec 31, 2022 -108.49 Mn
Sep 30, 2022 33.00 Mn
Jun 30, 2022 24.74 Mn
Mar 31, 2022 -76.81 Mn
Dec 31, 2021 112.42 Mn
Sep 30, 2021 17.90 Mn